Brand Name | Status | Last Update |
---|---|---|
fluorodopa | New Drug Application | 2021-01-15 |
Expiration | Code | ||
---|---|---|---|
FLUORODOPA F-18, FLUORODOPA F18, FEINSTEIN | |||
2024-10-10 | NCE, W |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | — | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 3 | — | — | — | — | 3 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | 1 | 2 |
Neoplasms | D009369 | — | C80 | 2 | — | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | — | — | — | — | 1 | 1 |
Melanoma | D008545 | — | — | — | — | — | — | 1 | 1 |
Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | — | — | — | 1 | 1 |
Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 1 | 1 |
Autoimmune diseases | D001327 | EFO_0000540 | M30-M36 | — | — | — | — | 1 | 1 |
Drug common name | Fluorodopa f 18 |
INN | fluorodopa (18f) |
Description | 6-((18)F)fluoro-L-dopa is a 6-fluoro-L-dopa and a (18)F radiopharmaceutical. |
Classification | Small molecule |
Drug class | dopamine receptor agonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O |
PDB | — |
CAS-ID | 92812-82-3 |
RxCUI | — |
ChEMBL ID | CHEMBL3400972 |
ChEBI ID | 49166 |
PubChem CID | 56494 |
DrugBank | DB13848 |
UNII ID | 2C598205QX (ChemIDplus, GSRS) |